Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Short Communication

Emerging Antibiotic Resistance of Blood Stream Infections among Children

Rabindran*, Viswanathan D and Devarajan V
Department of Neonatology, Billroth Hospital, Chennai, India
Corresponding Author : Rabindran
Consultant Neonatologist
Billroth Hospital, No.43, Lakshmi Talkies Road
Shenoy Nagar, Chennai, India
Tel: 044-42921788
Email: rabindranindia@yahoo.co.in
Received: October 13, 2015; Accepted: October 20, 2015; Published: October 27, 2015
Citation: Rabindran, Viswanathan D, Devarajan V (2015) Emerging Antibiotic Resistance of Blood Stream Infections among Children. J Infect Dis Ther 3:247. doi:10.4172/2332-0877.1000247
Copyright: © 2015 Rabindran et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at Pubmed, Scholar Google

Abstract

Antibiotic resistance is a serious problem in the management of childhood infections. Bacteria have developed various mechanisms of resistance. Indiscriminate and irrational use of antibiotics have led to the emergence of superbugs which have developed resistance to multiple antibiotics. Nowadays research are showing promising role of usage of older antibiotics for treatment of resistant infections. Multidrug resistant gram negative infections is a challenging situation where combination therapy and drugs with gram positive coverage like vancomycin are showing positive results. Ampicillin is losing sensitivity and protocols have been modified in using cephalosporins as the first line in some units. Carbapenam resistance and ESBL are emerging among hospitalised patients. Similarly emergence of community acquired MRSA possessing a new virulence toxin (Panton-Valentine leukocidin) is a serious threat among childhood infections. Unfortunately of late only minimal resources are directed to the development of newer antibiotics. Its time to consider the emerging antibiotic resistance particularly among children as a serious issue and start rational antibiotic practice and develop unit specific antibiotic policy to fight against antibiotic resistance.

Keywords

Top